4.8 Review

Nanotoxicology and nanomedicine: The Yin and Yang of nano-bio interactions for the new decade

Journal

NANO TODAY
Volume 39, Issue -, Pages -

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.nantod.2021.101184

Keywords

Nanotoxicology; Nanomedicine; Microbiome; Coronavirus; Protein corona; NanoEL

Funding

  1. Estonian Research Council [PUT1015]
  2. ERDF project [TK134]
  3. European Union [835140, 731032]
  4. Australian Research Council [CE140100036]
  5. United States National Institute of Environmental Health Sciences of the National Institutes of Health, Nanotechnology Health Implications Research (NHIR) Consortium [U01ES027237]
  6. NSFC [21607115, 21777116]
  7. Cluster of Excellence 'Advanced Imaging of Matter' of the Deutsche Forschungsgemeinschaft (DFG) [EXC 2056, 390715994]
  8. Marie Curie Actions (MSCA) [835140] Funding Source: Marie Curie Actions (MSCA)

Ask authors/readers for more resources

Nanotoxicology and nanomedicine are two sub-disciplines of nanotechnology that focus on nano-bio interface, with shared goals and challenges. In recent years, the relationship between the two fields has become closer, and their joint development can bring greater benefits to human health and environmental safety.
Nanotoxicology and nanomedicine are two sub-disciplines of nanotechnology focusing on the phenomena, mechanisms, and engineering at the nano-bio interface. For the better part of the past three decades, these two disciplines have been largely developing independently of each other. Yet recent breakthroughs in microbiome research and the current COVID-19 pandemic demonstrate that holistic approaches are crucial for solving grand challenges in global health. Here we show the Yin and Yang relationship between the two fields by highlighting their shared goals of making safer nanomaterials, improved cellular and organism models, as well as advanced methodologies. We focus on the transferable knowledge between the two fields as nanotoxicological research is moving from pristine to functional nanomaterials, while inorganic nanomaterials - the main subjects of nanotoxicology - have become an emerging source for the development of nanomedicines. We call for a close partnership between the two fields in the new decade, to harness the full potential of nanotechnology for benefiting human health and environmental safety. (c) 2021 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available